Press release
Liver Fibrosis Market to Reach US$ 4,897.7 Million by 2033, at CAGR of 7.7% from 2023 to 2033, IMARC Group
How big is the market for liver fibrosis?
According to IMARC Group, in 2022, the total value of the seven major markets (7MM) for liver fibrosis market amounted to US$ 2,152.0 Million. Looking forward, these markets are anticipated to reach US$ 4,897.7 Million by 2033, at a growth rate (CAGR) of 7.7% from 2023-2033.
Request for a Sample Report: https://www.imarcgroup.com/liver-fibrosis-market/requestsample
What is liver fibrosis?
Liver fibrosis is the result of the abnormal formation of fibrous tissue or scarring in the liver due to injury or damage. With time, the accumulation of scar cells can cause the liver to become rigid and lose its normal functionality. Individuals affected by this condition may experience reduced appetite, cognitive difficulties, fluid retention in the legs or abdomen, breathlessness, nausea, unexplained weight loss, muscle weakness, etc. The diagnosis of liver fibrosis includes a complete evaluation of the patient's medical history, a liver biopsy, and various diagnostic procedures, such as ultrasonography, computed tomography, magnetic resonance imaging, etc.
Explore the Full Report with Table of Contents: https://www.imarcgroup.com/liver-fibrosis-market
What are the key drivers and trends in the liver fibrosis market?
The growing cases of injury and inflammation in the liver, which lead to an excessive buildup of proteins between the hepatic cells, are primarily driving the liver fibrosis market. Besides this, the increasing instances of various associated risk factors, such as daily alcohol consumption, obesity, destruction of the bile ducts, autoimmune hepatitis, etc., are also augmenting the market growth. Moreover, the rising utilization of antifibrotic drugs, including belapectin, cenicriviroc, liraglutide, etc., that help minimize the likelihood of permanent liver scarring in patients is acting as another significant growth-inducing factor.
Additionally, the inflating demand for next-generation plasma protein profiling, as it aids in understanding the disease mechanisms that can guide personalized treatment strategies, is positively influencing the market growth. Furthermore, the increasing popularity of cell therapy for the curing of this illness, owing to its ability to repair or replace damaged cells in the liver and promote the production of hepatic enzymes, is expected to propel the liver fibrosis market in the coming years.
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033
Countries Included:
United States
Germany
France
United Kingdom
Italy
Spain
Japan
Analysis Covered Across Each Country
Historical, current, and future epidemiology scenario
Historical, current, and future performance of the liver fibrosis market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the liver fibrosis market
Reimbursement scenario in the market
In-market and pipeline drugs
In-Market Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/request?type=report&id=7697&flag=C
How This Report Can Help You:
The report on liver fibrosis market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the liver fibrosis market.
The liver fibrosis market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
Our report on the liver fibrosis market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
Browse Our Latest Healthcare Research Report:
Major Depressive Disorder Market Report 2023-2033: https://www.imarcgroup.com/major-depressive-disorder-market
Malignant Pleural Mesothelioma Market Report 2023-2033: https://www.imarcgroup.com/malignant-pleural-mesothelioma-market
Myelodysplastic Syndrome Market Report 2023-2033: https://www.imarcgroup.com/myelodysplastic-syndrome-market
Opioid-Induced Constipation Market Report 2023-2033: https://www.imarcgroup.com/opioid-induced-constipation-market
Key Questions Answered in this Report:
How has the liver fibrosis market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the liver fibrosis market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the liver fibrosis market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: -
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Fibrosis Market to Reach US$ 4,897.7 Million by 2033, at CAGR of 7.7% from 2023 to 2033, IMARC Group here
News-ID: 3127836 • Views: …
More Releases from IMARC Group
Automotive Control Cables Manufacturing Plant Setup Report 2025: Machinery, Raw …
Automotive control cables are essential components used to transmit mechanical force in vehicles, enabling the smooth operation of various systems such as brakes, clutches, accelerators, gear shifts, and seating mechanisms. These cables are designed for durability, flexibility, and high performance under diverse driving conditions. Their demand is directly linked to the growth of the automotive industry, aftermarket sales, and increasing consumer preference for enhanced driving comfort and safety.
Setting up an…
Halal Cosmetics Market Size, Trends, Key Players, Opportunity and Forecast 2025- …
IMARC Group, a leading market research company, has recently released a report titled "Halal Cosmetics Market Size, Share, Trends and Forecast by Type, Distribution Channel, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global halal cosmetics market size, trends, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Halal Cosmetics Market Highlights:
• Halal Cosmetics Market…
Comprehensive Castor Oil Processing Plant Project Report 2025: Setup Guide, Econ …
Castor oil is a versatile vegetable oil extracted from the seeds of the Ricinus communis plant. It is widely used in pharmaceuticals, cosmetics, food processing, lubricants, paints, coatings, and biodiesel production owing to its unique chemical properties, including high ricinoleic acid content. Castor oil derivatives also serve as key raw materials in the polymer, chemical, and industrial sectors.
Establishing a castor oil processing plant involves steps such as seed cleaning, dehulling,…
Honey Processing Plant Report 2025: Capital Investment, Operating Expenses and M …
Honey is a natural sweetener produced by honeybees and is valued for its nutritional, medicinal, and industrial applications. It contains antioxidants, enzymes, vitamins, and minerals that make it a popular ingredient in food and beverages, pharmaceuticals, cosmetics, and personal care products. Processed honey is widely consumed as a sweetener, used in bakery and confectionery items, beverages, dietary supplements, and skincare formulations.
Setting up a honey processing plant involves operations such as…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
